| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes ADVANCE Collaborative Group New England journal of medicine 358 (24), 2560-2572, 2008 | 10182 | 2008 |
| Intensive versus conventional glucose control in critically ill patients Nice-Sugar Study Investigators New England Journal of Medicine 360 (13), 1283-1297, 2009 | 6041 | 2009 |
| Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 | 5364 | 2019 |
| Hydroxyethyl starch or saline for fluid resuscitation in intensive care JA Myburgh, S Finfer, R Bellomo, L Billot, A Cass, D Gattas, P Glass, ... New England Journal of Medicine 367 (20), 1901-1911, 2012 | 2067 | 2012 |
| Intensity of continuous renal-replacement therapy in critically ill patients RENAL Replacement Therapy Study Investigators New England Journal of Medicine 361 (17), 1627-1638, 2009 | 1700 | 2009 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 832 | 2014 |
| Adjunctive glucocorticoid therapy in patients with septic shock B Venkatesh, S Finfer, J Cohen, D Rajbhandari, Y Arabi, R Bellomo, ... New England Journal of Medicine 378 (9), 797-808, 2018 | 819 | 2018 |
| SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis BL Neuen, T Young, HJL Heerspink, B Neal, V Perkovic, L Billot, ... The lancet Diabetes & endocrinology 7 (11), 845-854, 2019 | 813 | 2019 |
| Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial CK Chow, J Redfern, GS Hillis, J Thakkar, K Santo, ML Hackett, S Jan, ... Jama 314 (12), 1255-1263, 2015 | 732 | 2015 |
| Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial S Thom, N Poulter, J Field, A Patel, D Prabhakaran, A Stanton, ... Jama 310 (9), 918-929, 2013 | 501 | 2013 |
| An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial RENAL Replacement Therapy Study Investigators Critical care medicine 40 (6), 1753-1760, 2012 | 320 | 2012 |
| Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups: results … KW Mahaffey, MJ Jardine, S Bompoint, CP Cannon, B Neal, ... Circulation 140 (9), 739-750, 2019 | 279 | 2019 |
| Sodium‐glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis C Arnott, Q Li, A Kang, BL Neuen, S Bompoint, CSP Lam, A Rodgers, ... Journal of the American Heart Association 9 (3), e014908, 2020 | 233 | 2020 |
| A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk A Patel, A Cass, D Peiris, T Usherwood, A Brown, S Jan, B Neal, GS Hillis, ... European journal of preventive cardiology 22 (7), 920-930, 2015 | 181 | 2015 |
| Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial GJ Hankey, ML Hackett, OP Almeida, L Flicker, GE Mead, MS Dennis, ... The Lancet Neurology 19 (8), 651-660, 2020 | 134 | 2020 |
| Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive ... Intensive care medicine 41, 1037-1047, 2015 | 125 | 2015 |
| Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial CMP Jones, RO Day, BW Koes, J Latimer, CG Maher, AJ McLachlan, ... The Lancet 402 (10398), 304-312, 2023 | 84 | 2023 |
| Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study M Jun, R Bellomo, A Cass, M Gallagher, S Lo, J Lee, ... Critical care medicine 42 (8), 1756-1765, 2014 | 57 | 2014 |
| CREDENCE Trial Investigators V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... Canagliflozin and renal outcomes in type 2 diabetes and nephropathy 2295, //doi, 0 | 47 | |
| Early acid–base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis R Bellomo, M Lipcsey, P Calzavacca, M Haase, A Haase-Fielitz, E Licari, ... Intensive care medicine 39, 429-436, 2013 | 38 | 2013 |